Core Viewpoint - Recent activities involving shareholders of Lattice Technology (06809) indicate significant investment interest, with notable stock deposits and purchases reflecting confidence in the company's future performance [1] Group 1: Shareholder Activities - On February 13, Lattice Technology's shareholders deposited stocks into Huatai Hong Kong, with a market value of HKD 1.802 billion, representing 13.04% of the total shares [1] - On February 10, JPMorgan increased its stake in Lattice Technology by acquiring 1.13246 million shares at a price of HKD 177.6932 per share, totaling approximately HKD 201 million [1] - Following the acquisition, JPMorgan's total holdings in Lattice Technology rose to approximately 8.6152 million shares, with a new ownership percentage of 13.07% [1]

Core Viewpoint - The article discusses the current funding logic in the market, highlighting the significant movements of public funds in the technology sector, particularly in the semiconductor and biopharmaceutical industries, as they adjust their portfolios based on performance and valuation metrics [3][8]. Group 1: Public Fund Movements - Public funds have shown a notable shift in their holdings, particularly in the STAR Market, with the STAR 50 Index rising by 12.1% this year [3][4]. - The total market capitalization of STAR Market companies reached 10.4 trillion yuan, with the technology sector dominating, accounting for 62.1% of the total market cap [5][6]. - The semiconductor industry remains the core focus for fund allocation, with 12 companies in the sector having a market capitalization exceeding 10 billion yuan [9][11]. Group 2: Semiconductor Sector Insights - The market's pricing anchor for the semiconductor sector has shifted from "valuation expansion" to "performance realization," emphasizing the importance of actual earnings [13][14]. - Key drivers for future growth in the semiconductor sector include strong order backlogs, profit growth through acquisitions and expansions, and sustained price increases in advanced processes [13][14]. - Public funds have significantly increased their holdings in semiconductor materials, chip design, and equipment, with companies like ShenGong Co. seeing an 11% increase in fund holdings [15][21]. Group 3: Biopharmaceutical Sector Insights - The biopharmaceutical sector is a critical area for public funds, with major holdings in companies like BeiGene and United Imaging Healthcare, although the sector has faced a reduction in holdings for several key companies [24][26]. - The article notes that innovative drug companies are currently under pressure, with significant reductions in holdings observed in companies like BaiLi TianHeng and RongChang Biopharma [26][28]. - Despite the challenges, companies with strong earnings potential and innovative drug pipelines are still attracting interest from public funds, indicating a selective investment approach [35][40].

Group 1 - The Hong Kong IPO market is experiencing a "dual increase" in both quality and quantity, with a strong preference for globally competitive "Chinese champion" companies [1][2] - The trend of "China for global" is gaining recognition among international investors, leading to a diverse range of companies seeking to list in Hong Kong for international business expansion [2][3] - The active IPO market is expected to enhance liquidity, which in turn can positively impact valuations, creating a virtuous "flywheel effect" [1][5] Group 2 - The shift in motivations for companies going public has evolved, with many now viewing listing in Hong Kong as a strategic step for internationalization rather than just a means of raising funds [2][3] - Regulatory support from both the Chinese and Hong Kong authorities has facilitated the listing process for high-quality A-share companies, encouraging them to seek international capital markets [2][5] - The anticipated IPO market in 2026 is expected to remain active, driven by an increase in listings from quality A-share companies and emerging sectors like AI and semiconductors [3][5] Group 3 - International investors are increasingly recognizing the value of Chinese companies, particularly those in manufacturing and high-growth sectors such as semiconductors and AI [6] - The presence of international cornerstone investors in recent IPOs indicates a growing confidence in the Hong Kong market and Chinese companies [5][6] - The Hong Kong market offers significant long-term value for companies, providing efficient capital-raising opportunities and facilitating rapid growth through streamlined refinancing processes [6]

Group 1 - Morgan Stanley increased its stake in Lattice Semiconductor (06809) by 1.13246 million shares at a price of 177.6932 HKD per share, totaling approximately 201 million HKD [1][3] - After the increase, Morgan Stanley's total shareholding in Lattice Semiconductor is approximately 8.6152 million shares, representing a stake of 13.07% [1][3]

证券日报网讯2月13日，澜起科技在互动平台回答投资者提问时表示，DRAM内存模组(如RDIMM和 MRDIMM)属于服务器主内存，与HBM的应用场景不同，分别有相对独立的市场空间，二者都将受益于 AI产业的发展，并非竞争或替代关系。公司经营情况正常。 ...

智通财经APP获悉，香港联交所最新资料显示，2月10日，摩根大通增持澜起科技(06809)113.246万股， 每股作价177.6932港元，总金额约为2.01亿港元。增持后最新持股数目约为861.52万股，最新持股比例 为13.07%。 ...

智通财经APP获悉，香港联交所最新资料显示，2月10日，摩根大通增持澜起科技(06809)113.246万股， 每股作价177.6932港元，总金额约为2.01亿港元。增持后最新持股数目约为861.52万股，最新持股比例 为13.07%。 ...

（原标题：澜起科技(06809)因超额配股权获悉数行使而发行988.35万股） 智通财经APP讯，澜起科技(06809)发布公告，于2026年2月13日因超额配股权获悉数行使而发行及配发 988.35万股H股。 fund ...

澜起科技(06809)发布公告，于2026年2月13日因超额配股权获悉数行使而发行及配发988.35万股H股。 ...

Group 1 - The core viewpoint of the news highlights the significant surge in Chinese AI model stocks, particularly with companies like Zhiyu and MiniMax experiencing substantial price increases, with Zhiyu rising over 130% in five trading days and MiniMax increasing over 40% in the same period [1] - The launch of new AI models such as GLM-5 by Zhiyu and Minimax 2.5 by MiniMax is expected to drive further interest and investment in the sector, with additional models from Alibaba and ByteDance anticipated to be released around the Chinese New Year [1] - Korean retail investors are actively purchasing Chinese AI model stocks, indicating a shift in investment preferences towards emerging technology companies, as evidenced by their buying patterns in the Hong Kong stock market [2][4] Group 2 - Data from the Korea Securities Depository shows that Korean investors have favored stocks like MiniMax and various ETFs related to Chinese technology and semiconductors, reflecting a strong interest in these sectors [2][3] - The Korean stock market has seen a remarkable increase, with the composite index rising by 130% since 2025, largely driven by a few major stocks like Samsung Electronics and SK Hynix, which have contributed significantly to the overall market performance [6][7] - The trend of Korean retail investors converting their currency to invest in foreign markets, including the Chinese stock market, has raised concerns about the depreciation of the Korean won, as highlighted by the Bank of Korea [10][11]